Stock listing
Genetic Analysis As
Selected listing: 8V8 · FWB · EUR · DE
Genetic Analysis As (Frankfurt:8V8). Latest release May 28, 2026: Norway's Genetic Analysis Q1 gross margin hurt by US duties, currency impact.
- Ticker
- Frankfurt:8V8
- Asset type
- Stock
- Exchange
- Frankfurt
- Currency
- EUR
About Genetic Analysis As
Genetic Analysis AS, trading under the ticker 8V8, is a public company based in Germany. The company specializes in genetic analysis technologies and solutions. Its focus is on providing innovative tools for various applications in healthcare and research. Genetic Analysis AS aims to enhance understanding and utilization of genetic data for improved outcomes.
Latest news from Genetic Analysis As
Norway's Genetic Analysis Q1 gross margin hurt by US duties, currency impact
May 28, 2026
Genetic Analysis: Record sales, narrowed losses, and global expansion marked a strong year in microbiome diagnostics
February 27, 2026
Genetic Analysis: Q3 2025 sales rose 2.9% year-over-year, with new product launches and US expansion driving growth
November 27, 2025
Genetic Analysis: Q2 2025 delivered strong sales growth, positive EBITDA, and strategic expansion in key markets
August 27, 2025
Genetic Analysis: Sales down, margins up, China entry and capital raise position GA for future growth
May 27, 2025